Oncotarget Promoting Communication Among Scientists

Oncotarget is the title of a popular online medical journal. It is the largest peer-reviewed journal in the world. Oncotarget has been hard at work all year expanding its publication and scope.

Oncotarget makes its new publications two times a week. It is n open-access biomedical research that features studies in a variety of fields such as autophagy, aging, microbiology, immunology, chromosomes, and pathology. It is looking to expand its scope. Check the journal at SCImago Journal & Country Rank.

Earlier in 2017, the online medical journal gave four awards in the form of travel grants to four of the biomedical researchers so that they could attend the conference Frontiers in Cancer Science 2017 which was to take place in Singapore in November 2017. The biomedical scientists who received the award were from th National Institute of Immunology of India, the Aligarh Muslim University, and the University of Toronto. The goal of the awards is to enable scientists from different parts of the world to meet and communicate, to exchange ideas and form connections. Oncotarget is dedicated to spreading cancer research and hopes that bringing scientists together will help the study reach better results.

The researchers that received the trave sponsorship presented several studies on various topics. Some were assessing the impact that drug treatments have on kidney cancer, and others presented the characteristics of chemoresistance that asbestos-related tumors have.
Learn more: https://www.ncbi.nlm.nih.gov/pmc/journals/1558/

Mohd Anas Shamsi of the Department of Biochemistry F/O Life Sciences of the Aligarh Muslim University talked about the implications of the Anti-renal cancer drug. Of the Indian National Institute of Immunology Rajni Kumari proliferative and metastatic genes. Ruhi Sandeep Deshmukh of the Molecular Oncology laboratory of the same university presented Cyclin F as a regulator of the Glioma Epigenetics. Of the Italian University of Torino, Vladan Milosevic talked about the chemoresistance in cancer stem cells.

The conference Frontiers in Cancer Science 2017 took place from November 6 until November 8. It was hosted by seven prominent research institutes including the Institute of Molecular and Cell Biology, the Lee Kong Chian School of Medicine, the Duke- NUS Medical School, the Cancer Science Institute of Singapore, as well as the Genome Institute of Singapore. Watch this video on Youtube.


No Comments (yet)

Leave a Reply

Comments RSS Subscribe to the Comments RSS.